Clinical Trials Browser

OTHER × Hyperinsulinism × dapagliflozin × Clear all

NCT05989347 2026-05-22

Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy

Phase 1 Recruiting

Breast Neoplasms, Hyperinsulinism